Medtronic PLC (MDT)

Return on total capital

Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Apr 26, 2024 Jan 31, 2024 Jan 26, 2024 Oct 31, 2023 Oct 27, 2023 Jul 31, 2023 Jul 28, 2023 Apr 30, 2023 Apr 28, 2023 Jan 31, 2023 Jan 27, 2023 Oct 31, 2022 Oct 28, 2022 Jul 31, 2022 Jul 29, 2022
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 4,871,000 6,715,000 6,051,000 5,834,000 6,093,000 5,787,000 6,225,000 6,093,000 5,787,000 5,987,000 6,224,000 6,347,000 6,543,000 6,202,000 5,978,000 5,607,000 5,277,000 5,717,000 5,951,000 6,421,000
Long-term debt US$ in thousands 21,700,000 21,100,000 20,100,000
Total stockholders’ equity US$ in thousands 48,024,000 49,387,000 48,494,000 47,947,000 50,214,000 50,214,000 51,792,000 51,792,000 51,460,000 51,460,000 51,178,000 51,178,000 51,483,000 51,483,000 51,441,000 51,441,000 51,880,000 51,880,000 52,672,000 52,672,000
Return on total capital 10.14% 13.60% 12.48% 12.17% 12.13% 11.52% 12.02% 11.76% 11.25% 11.63% 12.16% 12.40% 12.71% 8.47% 11.62% 10.90% 10.17% 7.83% 11.30% 8.82%

April 30, 2025 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $4,871,000K ÷ ($—K + $48,024,000K)
= 10.14%

The return on total capital for Medtronic PLC has shown variability over the analyzed periods, ranging from as low as 7.83% on October 28, 2022, to a high of 13.60% on January 31, 2025. Overall, the company's return on total capital demonstrates a generally upward trend, with fluctuations within a relatively narrow range. The return on total capital metrics indicate the efficiency of Medtronic PLC in generating profits from the total capital employed in its operations. A higher return on total capital suggests that the company is effectively utilizing its resources to generate returns for its investors.